CGC SHAREHOLDER ALERT: Jakubowitz Law Reminds Canopy Growth Shareholders of a Lead Plaintiff Deadline of July 24, 2023
NEW YORK, June 14, 2023 (GLOBE NEWSWIRE) -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Canopy Growth Corporation (NASDAQ: CGC).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/canopy-growth-class-action-loss-submission-form/?id=40781&from=3
The lawsuit seeks to recover losses for shareholders who purchased Canopy Growth between May 31, 2022 and May 10, 2023.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until July 24, 2023 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Canopy Growth Corporation issued materially false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company’s internal controls over accounting and financial reporting; (2) as a result, the Company improperly booked sales of its BioSteel business unit; (3) as a result, the Company’s revenue was overstated; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.